The CRISPR revolution in plant disease management
|
Ngangbam Punita and Snata Kaushik
Contd from previous issue
On the other hand, the Court of Justice of the European Union (CJEU) ruled that genome-edited crops created by CRISPR/Cas are to be regulated the same as GMOs. These contrasting regulatory approaches based on the process versus the product have created a convoluted landscape for politician, scientists, and the general public alike to navigate when it comes to policy, ethics, and commercialization of gene edited crops. Clear and uniform positions on government regulations among countries globally are needed to maximize the impact of CRISPR technologies.
CRISPR technology is the solution to many problems, not only in disease management, plant pathology or agriculture but in science as a whole. Despite the potential and promises for practical applications in plant pathology and disease management, various technical, regulatory and social limitations associated with the commercialization of genome editing technologies must be properly resolved for the world agricultural industry to benefit from the CRISPR revolution. Ms. Ngangbam Punita Scholar : Ph.D. (Plant Pathology), College of Post Graduate Studies in Agricultural Sciences, Umiam, Meghalaya Central Agricultural University, Imphal, 795004, Mani-pur, India Email: punitangang-bam 73836@ gmail.com
Ms. Snata Kaushik Scholar: PhD (Plant Pathology), College of Post Graduate Studies in Agricultural Sciences, Umiam, Meghalaya Central Agricultural University, Imphal, 795004
Contd from previous issue
On the other hand, the Court of Justice of the European Union (CJEU) ruled that genome-edited crops created by CRISPR/Cas are to be regulated the same as GMOs. These contrasting regulatory approaches based on the process versus the product have created a convoluted landscape for politician, scientists, and the general public alike to navigate when it comes to policy, ethics, and commercialization of gene edited crops. Clear and uniform positions on government regulations among countries globally are needed to maximize the impact of CRISPR technologies.
CRISPR technology is the solution to many problems, not only in disease management, plant pathology or agriculture but in science as a whole. Despite the potential and promises for practical applications in plant pathology and disease management, various technical, regulatory and social limitations associated with the commercialization of genome editing technologies must be properly resolved for the world agricultural industry to benefit from the CRISPR revolution. Ms. Ngangbam Punita Scholar : Ph.D. (Plant Pathology), College of Post Graduate Studies in Agricultural Sciences, Umiam, Meghalaya Central Agricultural University, Imphal, 795004, Mani-pur, India Email: punitangang-bam 73836@ gmail.com
Ms. Snata Kaushik Scholar: PhD (Plant Pathology), College of Post Graduate Studies in Agricultural Sciences, Umiam, Meghalaya Central Agricultural University, Imphal, 795004